🔗 Share this article

Treasury head Rachel Reeves has stated she is planning "focused action to deal with household expense issues" in the upcoming Budget.

During an interview with media outlets, she emphasized that lowering price rises is a collective responsibility of both the administration and the Bank of England.

The UK's inflation rate is forecast to be the most elevated among the G7 advanced economies this year and the following year.

Possible Energy Bill Measures

Sources suggest the government could intervene to bring down energy bills, such as by cutting the present 5% rate of value-added tax applied on energy supplies.

An additional approach is to cut some of the government charges presently included in bills.

Fiscal Constraints and Expert Expectations

The administration will receive the latest draft from the official forecaster, the Office for Budget Responsibility, on Monday, which will show how much scope there is for such actions.

The view from most economists is that the Chancellor will have to declare higher taxes or budget cuts in order to adhere to her voluntary debt limits.

Previously on Thursday, analysis showed there was a £22 billion deficit for the Treasury chief to fill, which is at the more modest range of forecasts.

"There's a joint task between the central bank and the administration to bear down further on some of the sources of price increases," Reeves told reporters in Washington, at the yearly gatherings of the IMF and global financial institution.

Tax Pledges and International Concerns

While much of the attention has been on expected tax increases, the chancellor said the most recent data from the OBR had not altered her vow to election pledges not to increase tax levels on earnings tax, sales tax or social security contributions.

She blamed an "uncertain global environment" with increasing geopolitical and commercial tensions for the fiscal tax moves, probably to be directed on those "wealthiest."

International Economic Disputes

Addressing apprehensions about the United Kingdom's economic relations with the Asian nation she said: "The UK's security interests invariably take priority."

Recent statement by China to strengthen export controls on rare earths and other materials that are crucial for advanced tech manufacturing led US President Donald Trump to threaten an extra 100% tariff on goods from the Asian country, raising the possibility of an full-scale commercial conflict between the two largest economies.

The American finance chief called China's move "commercial pressure" and "a global supply chain power grab."

Asked about accepting the American proposal to join its conflict with China, the Chancellor said she was "extremely troubled" by Chinese measures and called on the Beijing authorities "not to put up barriers and limit trade."

She said the decision was "damaging for the global economy and generates additional obstacles."

"In my view there are areas where we need to address Chinese policies, but there are also significant prospects to trade with Chinese markets, including banking sector and other sectors of the economic system. We've got to achieve that equilibrium right."

The Treasury chief also affirmed she was cooperating with international partners "regarding our own critical minerals plan, so that we are reduced dependence."

Health Service Medicine Costs and Funding

Reeves also acknowledged that the price the NHS pays for pharmaceuticals could go up as a consequence of current talks with the Trump administration and its drugs companies, in return for reduced taxes and capital.

A number of the biggest global pharmaceutical manufacturers have said recently that they are either pausing or canceling investments in the United Kingdom, with several blaming the low prices they are receiving.

Recently, the Science Minister said the price the NHS spends on drugs would have to rise to prevent firms and drug research funding departing from the UK.

Reeves told media: "We have seen as a result of the pricing regime, that drug testing, recent pharmaceuticals have not been available in the United Kingdom in the extent that they are in other European countries."

"We want to guarantee that people getting care from the NHS are can receive the finest essential drugs in the globe. And so we are reviewing all of that, and... aiming to obtain additional investment into the UK."